The U.S. equity market has been anything but calm in 2025, as several factors, including persistent trade tensions, rising ...

Key Points Amgen offers an attractive dividend and significant upside potential. Vertex Pharmaceuticals is a great biotech ...

Vertex and Eli Lilly are revolutionizing non-opioid pain management with NaV1.8 advancements. See why I'm bullish about LLY ...

Phase 3 results revealed Monday led shares to surge and should yield an approval application in IgA nephropathy, a ...